Mega Lifesciences PCL

Common Name
Mega Lifesciences
Country
Thailand
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
N/A
Ticker
MEGA
Exchange
STOCK EXCHANGE OF THAILAND
Description
Mega Lifesciences Public Company Limited is a prominent player in the global pharmaceutical and healthcare industry. Primarily, it engages in the development, manufacturing, marketing, and distributio...

Mega Lifesciences's GHG Emissions Data Preview

In 2023, Mega Lifesciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Mega Lifesciences has also provided a category-level breakdown for 1 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Mega Lifesciences's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Mega Lifesciences’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Mega Lifesciences’s data sources below and access millions more through our Disclosure Search.

a. Mega Lifesciences's Annual Report 2023
Trace every data point back to Mega Lifesciences’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Mega Lifesciences's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Mega Lifesciences amounted to 8,561.46 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Mega Lifesciences increased by 1,280.72%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Mega Lifesciences's Scope 1 Emissions Over Time

20182019202020212022202305001 k1.5 k2 ktCO2e-25%-12%-10%-13%+1389%
  • Total Scope 1
  • Year-over-Year Change

What are Mega Lifesciences's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Mega Lifesciences were 1,808.57 metric tons of CO₂ equivalent (tCO₂e). a

Has Mega Lifesciences reduced its Scope 1 emissions over time?

Since 2018, Mega Lifesciences's Scope 1 emissions have increased by 670.26%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), Mega Lifesciences's Scope 1 emissions increased by 1,389.27%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Mega Lifesciences's Scope 2 emissions?

In 2023, Mega Lifesciences reported Scope 2 greenhouse gas (GHG) emissions of 6,752.89 tCO₂e without specifying the calculation method. a

Has Mega Lifesciences reduced its Scope 2 emissions over time?

Since 2018, Mega Lifesciences's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 857.68%, reflecting a rising long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2022), Mega Lifesciences's Scope 2 emissions (Unspecified Calculation Method) rose by 1,254.29% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a

What methodology does Mega Lifesciences use for Scope 2 reporting?

In 2023, Mega Lifesciences reported its Scope 2 emissions using an unspecified methodology. a

Mega Lifesciences's Scope 2 Emissions Over Time

20182019202020212022202302 k4 k6 k8 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Mega Lifesciences's Value Chain Emissions

In 2023, Mega Lifesciences reported 6,752.89 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2023 disclosure of Mega Lifesciences includes a breakdown across 1 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Mega Lifesciences's Scope 3 Emissions Over Time

20182019202020212022202302 k4 k6 k8 ktCO2e-14%+1%-5%-15%+1254%
  • Total Scope 3
  • Year-over-Year Change

What are Mega Lifesciences's Scope 3 emissions?

In 2023, Mega Lifesciences reported total Scope 3 emissions of 6,752.89 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a

Has Mega Lifesciences reduced its Scope 3 emissions over time?

Since 2018, Mega Lifesciences's Scope 3 emissions have increased by 857.68%, reflecting a rising long-term trend in Scope 3 emissions over time. a

Compared to the previous year (2022), Mega Lifesciences's Scope 3 emissions increased by 1,254.29%, suggesting that the company faced challenges in reducing emissions across its value chain. a

What categories of Scope 3 emissions does Mega Lifesciences disclose?

In 2023, Mega Lifesciences reported emissions for 1 out of the 15 Scope 3 categories defined by the GHG Protocol. a

The limited disclosure restricts visibility into specific emission sources across the company's value chain.

What are the main sources of Mega Lifesciences's Scope 3 emissions?

In 2023, the largest contributors to Mega Lifesciences's Scope 3 emissions were: a

  • Fuel- and Energy-Related Services (Cat. 3): 439.53 tCO₂e (100%)

Mega Lifesciences's Scope 3 Emissions by Categories

Fuel- andEnergy-RelatedServices (Cat. 3)(100.0%)

Insights into Mega Lifesciences's Total Carbon Footprint

In 2023, Mega Lifesciences reported a total carbon footprint of 15,314.35 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1,268.94% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Mega Lifesciences's total carbon footprint was Scope 2 emissions, accounting for 44.1% of the company's total carbon footprint, followed by Scope 3 emissions at 44.1%. a

Want Full Access to Mega Lifesciences's GHG Emissions Dataset?
Sign Up